First 10 runs free
    Intelligence Feed event · Equity · 2026-11-12

    GE HealthCare lifts 2026 organic revenue guidance to 4% on $23.7B backlog

    Question

    GE HealthCare lifts 2026 organic revenue guidance to 4% on $23.7B backlog

    Direct answer

    GE HealthCare upwardly revised its 2026 organic revenue guidance to 4% following a 6.2% organic growth pace in the third quarter. The company reported total equipment backlog expansion of 12% year-over-year to $23.7 billion, supported by recurring demand in its Pharmaceutical Diagnostics business.

    Original publisher
    Market Ontology
    Evidence through
    2026-11-12
    Published
    2026-11-12
    Revision
    1 · 2026-11-12

    Cite as: Market Ontology, “GE HealthCare lifts 2026 organic revenue guidance to 4% on $23.7B backlog”, revision 1, evidence through 2026-11-12. https://marketontology.com/market-events/2026-11-12/ge-healthcare-lifts-2026-organic-revenue-guidance-to-4-on-23-7b-backlog-e5ca30

    EQUITY
    GE HealthCare lifts 2026 organic revenue guidance to 4% on $23.7B backlog
    GE HealthCare upwardly revised its 2026 organic revenue guidance to 4% following a 6.2% organic growth pace in the third quarter. The company reported total equipment backlog expansion of 12% year-over-year to $23.7 billion, supported by recurring demand in its Pharmaceutical Diagnostics business.
    GEHC
    Impact
    70
    NOV 12
    SIG
    82%
    GEHC
    GE HealthCare lifts 2026 organic revenue guidance to 4% on $23.7B backlog
    GE HealthCare upwardly revised its 2026 organic revenue guidance to 4% following a 6.2% organic growth pace in the third quarter. The company reported total equipment backlog expansion of 12% year-over-year to $23.7 billion, supported by recurring demand in its Pharmaceutical Diagnostics business.
    → A 12% expansion in hospital equipment backlog to $23.7 billion secures multi-quarter revenue visibility for GEHC against medtech supply headwinds.
    Impact
    GE HealthCare upwardly revised its 2026 organic revenue guidance to 4% following a 6.2% organic growth pace in the third quarter. The company reported total equipment backlog expansion of 12% year-over-year to $23.7 billion, supported by recurring demand in its Pharmaceutical Diagnostics business.
    Affected
    GEHC
    Transmission
    A 12% expansion in hospital equipment backlog to $23.7 billion secures multi-quarter revenue visibility for GEHC against medtech supply headwinds.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    GEHCguidance upward revision on commercial equipment backlogUp1-4wGE HealthCare raised full-year organic revenue guidance to 4% with equipment backlog at $23.7 billion.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    Price follow-up pending — no stored daily closes for these assets yet.

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    Find trades for this development

    Screen tradable expressions of this catalyst against your horizon and constraints. Nothing is submitted without your review.

    First 10 runs free

    First 10 runs free

    See today's live cards

    Public pages are published 24 hours after the product shows them. The product shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open live cards